These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6312728)

  • 1. Tranexamic acid for the treatment of advanced ovarian carcinoma.
    Sigurdsson K; Johnsson JE; Tropé C
    Acta Obstet Gynecol Scand; 1983; 62(3):265-6. PubMed ID: 6312728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant treatment of ovarian carcinoma with tranexamic acid.
    Astedt B
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():74-6. PubMed ID: 6933159
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of advanced ovarian cancer with fibrinolytic inhibitor (tranexamic acid).
    Soma H; Sashida T; Yoshida M; Miyashita T; Nakamura A
    Acta Obstet Gynecol Scand; 1980; 59(3):285-7. PubMed ID: 7424507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of advanced cancer with Cyclocapron (tranexamic acid)].
    Rutqvist LE; Bolund C; Friberg S; Einhorn N; Wallgren A
    Lakartidningen; 1977 Aug; 74(32):2679-80. PubMed ID: 895275
    [No Abstract]   [Full Text] [Related]  

  • 5. Arrest of growth of ovarian tumor by tranexamic acid.
    Astedt B; Glifberg I; Mattsson W; Tropé C
    JAMA; 1977 Jul; 238(2):154-5. PubMed ID: 577288
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trial of medroxyprogesterone acetate in advanced ovarian cancer: an EORTC Gynecological Cancer Cooperative Group Study.
    Hamerlynck JV; Maskens AP; Mangioni C; van der Burg ME; Wils JA; Vermorken JB; Rotmensz N
    Gynecol Oncol; 1985 Nov; 22(3):313-6. PubMed ID: 2998957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of Fluorouracil (5-FU) and leucovorin in women with heavily pretreated advanced ovarian carcinoma.
    Peled Y; Levavi H; Krissi H; Weill Y; Sabah G; Eitan R
    Am J Clin Oncol; 2013 Oct; 36(5):472-4. PubMed ID: 22706176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy.
    Bamias A; Psaltopoulou T; Sotiropoulou M; Haidopoulos D; Lianos E; Bournakis E; Papadimitriou C; Rodolakis A; Vlahos G; Dimopoulos MA
    Cancer; 2010 Mar; 116(6):1462-8. PubMed ID: 20108307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin and cyclophosphamide, alternated with bleomycin and mitomycin C as a second-line regimen in advanced ovarian carcinoma resistant to cisplatin-based chemotherapy.
    Benedetti Panici P; Scambia G; Greggi S; Salerno G; Cento R; Mancuso S
    Oncology; 1990; 47(4):296-8. PubMed ID: 1694980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of spirogermanium in advanced ovarian malignancy.
    Tropé C; Mattsson W; Gynning I; Johnsson JE; Sigurdsson K; Orbert B
    Cancer Treat Rep; 1981; 65(1-2):119-20. PubMed ID: 6261944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant effects of tranexamic acid to chemotherapy in ovarian cancer patients with large amount of ascites.
    Kikuchi Y; Kizawa I; Oomori K; Matsuda M; Kato K
    Acta Obstet Gynecol Scand; 1986; 65(5):453-6. PubMed ID: 3776488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bevacizumab combined with platinum-taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial).
    Komiyama S; Kato K; Inokuchi Y; Takano H; Matsumoto T; Hongo A; Asai-Sato M; Arakawa A; Kamiura S; Tabata T; Takeshima N; Sugiyama T
    Int J Clin Oncol; 2019 Jan; 24(1):103-114. PubMed ID: 30030657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab plus low-dose metronomic oral cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer.
    Sánchez-Muñoz A; Mendiola C; Pérez-Ruiz E; Rodríguez-Sánchez CA; Jurado JM; Alonso-Carrión L; Ghanem I; de Velasco G; Quero-Blanco C; Alba E
    Oncology; 2010; 79(1-2):98-104. PubMed ID: 21079407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined pegylated liposomal doxorubicin and carboplatin in the treatment of recurrent epithelial ovarian cancer].
    Zheng H; Gao YN; Jiang GQ; Gao M; Wang W; Yan X
    Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):839-42. PubMed ID: 19087568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tranexamic acid on choroidal melanoma.
    Bramsen T
    Acta Ophthalmol (Copenh); 1978 Apr; 56(2):264-9. PubMed ID: 580845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in ovarian cancer patients choosing to receive salvage chemotherapy or palliative treatment.
    Srisuttayasathien M; Khemapech N
    Asian Pac J Cancer Prev; 2013; 14(12):7669-74. PubMed ID: 24460351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base.
    Asare EA; Compton CC; Hanna NN; Kosinski LA; Washington MK; Kakar S; Weiser MR; Overman MJ
    Cancer; 2016 Jan; 122(2):213-21. PubMed ID: 26506400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cyklokapron (tranexamic acid) in the treatment of patients with advanced neoplasms].
    Fosså SD; Solheim O; Fosså J
    Tidsskr Nor Laegeforen; 1978 Oct; 98(28):1368-70. PubMed ID: 360480
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination chemotherapy for advanced ovarian cancer: a prospective randomized trial comparing hexamethylmelamine and cyclophosphamide to doxorubicin and cyclophosphamide.
    Schwartz PE; Lawrence R; Katz M
    Cancer Treat Rep; 1981; 65(1-2):137-41. PubMed ID: 6261948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of chemotherapy on the prognosis of ovarian cancer].
    Sugawa T; Umesaki N; Yajima A; Satoh S; Terashima Y; Ochiai K; Tomoda Y; Kanoh T; Noda K; Yakushiji M
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep; 44(9):1135-41. PubMed ID: 1333504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.